 |
J&J to pay $2.2bn to end US drug probesIn one of the largest health care fraud settlements in US history, Johnson & Johnson will pay $2.2 billion to end civil and criminal investigations into kickbacks to pharmacists and the marketing of pharmaceuticals for off-label uses, US Att More… |
Wednesday 6 November 2024
